Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

Press releases published on September 1, 2026

Sep. 1, 2026

Ono Pharma and Aitia Announce Collaboration to Identify Novel Drug Targets in Neurological Diseases

Indeterminate EIN Presswire

Sep. 1, 2026

New Addiction Treatment Center Opening This Fall on the North Shore

Indeterminate EIN Presswire

Sep. 1, 2026

Grant Marketing President Bob Grant Earns HubSpot Certificate in AEO Fundamentals

Indeterminate EIN Presswire

Sep. 1, 2026

GLOBAL HEALTH CATALYST SUMMIT 2026 TO LAUNCH AI-ENABLED CANCER CENTER IN THE CLOUD AT HARVARD/MIT

Indeterminate EIN Presswire

Sep. 1, 2026

Desert Hope Treatment Center Addresses Community Need for Increased Addiction Services with New Virtual Program

Indeterminate GlobeNewswire

Sep. 1, 2026

Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway

Indeterminate GlobeNewswire

Sep. 1, 2026

Pennant Group to Participate in the 2026 Jefferies Healthcare Services Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

HWH International Inc. Announces Executive Leadership Transition

Indeterminate GlobeNewswire

Sep. 1, 2026

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 1, 2026

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September

Indeterminate GlobeNewswire

Sep. 1, 2026

aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis

Indeterminate GlobeNewswire

Sep. 1, 2026

Teva to Present at Morgan Stanley, J.P. Morgan and BofA Investor Conferences in September

Indeterminate GlobeNewswire

Sep. 1, 2026

STERIS to Present at the Morgan Stanley Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Cellectis annonce sa participation à plusieurs conférences investisseurs

Indeterminate GlobeNewswire

Sep. 1, 2026

Cellectis Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Braveheart Bio to Participate in Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Tarsus to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 1, 2026

Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

LifeStance to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire